Response to hormonal therapy as a prognostic factor for metastatic breast cancer treated with combination chemotherapy
โ Scribed by Sewa S. Legha; Aman U. Buzdar; Terry L. Smith; Kenneth D. Swenerton; Gabriel N. Hortobagyi; George R. Blumenschein
- Publisher
- John Wiley and Sons
- Year
- 1980
- Tongue
- English
- Weight
- 688 KB
- Volume
- 46
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The Cancer and Leukemia Group B (CALGB) evaluated the response to subsequent chemotherapy or chemohormonal therapy in 46 patients with advanced breast cancer treated previously with adjuvant chemotherapy that had been completed 6 months or more before protocol entry. The results were compared with 3
A group of 154 patients with locally advanced head and neck cancer, treated with platinum-based induction chemotherapy, were followed up for 5 years and several pretreatment characteristics were analyzed for possible correlation to a complete response (CR) to chemotherapy, time to progression (TTP)